ARTICLE | Finance
Making Mubadala Capital Ventures
How the sovereign’s venture arm has integrated itself into the biotech ecosystem and become a company builder
August 25, 2023 6:45 PM UTC
It’s not easy to launch a biotech VC, but it doesn’t hurt to have a sovereign wealth fund with nearly $300 billion in assets under management behind you. In six short years, Mubadala Capital Ventures has evolved from Silicon Valley’s latest tech fund to biotech company creator and lead investor with a portfolio of more than two dozen biotechs.
The firm debuted in 2017 as part of the $17 billion AUM Mubadala Capital alternative asset management unit of Abu Dhabi-based Mubadala Investment Co., with an office in San Francisco, a $400 million fund with SoftBank joining the sovereign parent entity as one of two main investors, and a $200 million ventures fund of funds. ...